| # | Drug | Count |
|---|---|---|
| 0 | EZETIMIBE | 11 |
| 1 | INCLISIRAN | 11 |
| 2 | FENOFIBRATE | 9 |
| 3 | ROSUVASTATIN | 7 |
| 4 | EVOLOCUMAB | 5 |
| 5 | ROSUVASTATIN CALCIUM | 5 |
| 6 | METFORMIN | 3 |
| 7 | METFORMIN ER 500 MG | 3 |
| 8 | METFORMIN ER 750 MG | 3 |
| 9 | ADALIMUMAB | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INCLISIRAN | 11 | 0.0013 |
| 1 | GLYCOPYRROLATE AND FORMOTEROL FUMARATE | 1 | 0.0005 |
| 2 | FENOFIBRATE | 9 | 0.0003 |
| 3 | ROSUVASTATIN CALCIUM | 5 | 0.0002 |
| 4 | EZETIMIBE | 11 | 0.0001 |
| 5 | SIPONIMOD | 1 | 0.0001 |
| 6 | FEBUXOSTAT TABLETS 40 MG | 1 | 0.0001 |
| 7 | NIACIN | 1 | 0.0001 |
| 8 | ROSUVASTATIN | 7 | 0.0001 |
| 9 | ALIROCUMAB | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | PCSK9 Inhibitor [EPC] | 7 | 0.0003 |
| 1 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 9 | 0.0002 |
| 2 | Dietary Cholesterol Absorption Inhibitor [EPC] | 11 | 0.0001 |
| 3 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 1 | 0.0001 |
| 4 | Androgen [EPC] | 1 | 0.0000 |
| 5 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 6 | Parathyroid Hormone-Related Peptide Analog [EPC] | 1 | 0.0000 |
| 7 | Interleukin-12 Antagonist [EPC] | 2 | 0.0000 |
| 8 | Interleukin-23 Antagonist [EPC] | 2 | 0.0000 |
| 9 | Nicotinic Acid [EPC] | 1 | 0.0000 |